Integral Diagnostics Limited (ASX: IDX) - ETF Exposure

Current share price for IDX : $2.350 0.01 (0.43%)⁺

Integral Diagnostics (IDX) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It provides diagnostic services to patients and their referrers across Australia and New Zealand. IDX employs radiologists and diagnostic imaging specialists in a medical leadership model that ensures quality patient care, service, and access.

IDX General Information ⁺

ASX Code	IDX
Website	http://www.integraldiagnostics.com.au
Industry/Sector	Health Care Services
Market Cap ($M)	876
IDX Share Price	$2.350
Day High	$2.400
Day Low	$2.320
Last Close	$2.340
IDX Share Price Movement	$0.01 ( 0.43% )

Prices as at 16:40, 2 Sep 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to IDX

Integral Diagnostics Limited (IDX) is held across 16 ETFs spanning strategies that include health care services exposure . Its weighting in those funds means performance can have an outsized influence - when IDX moves, funds like IMPQ, MVS, SSO, ISO and MQAE that hold it can move with it.

For more concentrated exposure, ETFs such as IMPQ (eInvest Better Future (Managed Fund)) allocate about 2.3% to IDX , while the average exposure across all 16 ETFs that hold it is around 0.3% .

Top ETF holdings

eInvest Better Future (Managed Fund) (IMPQ) ~ 2.3%
VanEck Small Companies Masters ETF (MVS) ~ 1.4%
SPDR S&P/ASX Small Ordinaries Fund (SSO) ~ 0.3%
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) ~ 0.3%
Macquarie Core Australian Equity Active ETF (MQAE) ~ 0.1%

Last updated: ETF data and holdings as at 1 September 2026

Own IDX directly or through an ETF?

How does holding Integral Diagnostics Limited (IDX) shares directly compare to ETFs that include it?

	IDX Direct	IMPQ ASX	MVS ASX	SSO ASX	ISO ASX	MQAE ASX
Holdings	1 company	41 holdings	59 holdings	202 holdings	198 holdings	215 holdings
IDX Weight	100%	2.3%	1.4%	0.3%	0.3%	0.1%
Diversification	Single Stock	Broad	Broad	Broad	Broad	Broad
Annual Cost	Brokerage only	0.89% p.a.	0.49% p.a.	0.5% p.a.	0.55% p.a.	0.03% p.a.
Approx. Yield	4.7%	2.16%	2.72%	9.15%	4.29%	2.54%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not IDX's direct yield. Annual cost uses each ETF's MER.

IDX Exposure on $10,000 investment

How a $10,000 investment in Integral Diagnostics Limited (IDX) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Integral Diagnostics Limited (IDX)	Direct share	$2.350	-2.08%	-$208	$9,792
eInvest Better Future (Managed Fund) (IMPQ)	Equity - Australia Small/Mid Cap	$4.160	-4.15%	-$415	$9,585
VanEck Small Companies Masters ETF (MVS)	Equity - Australia Small/Mid Cap	$22.090	-2.77%	-$277	$9,723
SPDR S&P/ASX Small Ordinaries Fund (SSO)	Equity - Australia Small/Mid Cap	$14.660	-3.99%	-$399	$9,601
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO)	Equity - Australia Small/Mid Cap	$5.100	-3.95%	-$395	$9,605
Macquarie Core Australian Equity Active ETF (MQAE)	Equity - Australia Strategy	$12.180	-2.01%	-$201	$9,799

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Integral Diagnostics Limited (IDX) ETFs

16 ETFs hold Integral Diagnostics Limited (IDX).

ETF	IDX Weight	MER	Yield
eInvest Better Future (Managed Fund) (IMPQ)	2.3%	0.89%	2.16%
VanEck Small Companies Masters ETF (MVS)	1.4%	0.49%	2.72%
SPDR S&P/ASX Small Ordinaries Fund (SSO)	0.3%	0.5%	9.15%
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO)	0.3%	0.55%	4.29%
Macquarie Core Australian Equity Active ETF (MQAE)	0.1%	0.03%	2.54%
Dimensional Australian Core Equity (Managed Fund) (DACE)	0.1%	0.28%	2.97%
Dimensional Australian Value Trust - Active ETF (DAVA)	0%	0.34%	6.53%
Vanguard Ethically Conscious Australian Shares ETF (VETH)	0%	0.16%	2.84%
Global X Australia 300 ETF (A300)	0%	0.03%	2.96%
Vanguard Australian Shares Index ETF (VAS)	0%	0.07%	2.91%

View all 16 ETFs

Integral Diagnostics Limited (IDX) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	6¢	100%	28 Aug 2026	2 Oct 2026	-	-	-
Result	3.3¢	100%	4 Mar 2026	2 Apr 2026	-	-	-
HFResult	4¢	100%	29 Aug 2025	3 Oct 2025	-	-	-

See all dividends from Integral Diagnostics Limited (IDX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Integral Diagnostics Limited (IDX) price-sensitive announcements

IDX - FY26 Full Year Investor Presentation

Integral Diagnostics Limited's FY26 Full Year Investor Presentation highlights significant

Integral Diagnostics Limited (IDX)
25 Aug 2026 | 9:14 AM

IDX - FY26 Full Year Results Announcement

Integral Diagnostics Limited reported robust financial results for the fiscal year ending

Integral Diagnostics Limited (IDX)
25 Aug 2026 | 9:13 AM

IDX - FY26 Annual Report

In the FY26 Annual Report, Integral Diagnostics Limited (IDX) showcases significant financ

Integral Diagnostics Limited (IDX)
25 Aug 2026 | 9:13 AM

IDX - Preliminary FY26 Results and Appointment of New CFO

Integral Diagnostics Limited (IDX) reported preliminary financial results for FY26, with s

Integral Diagnostics Limited (IDX)
10 Aug 2026 | 9:05 AM

Integral Diagnostics Limited (IDX) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID	Health Care	$877	Notification of cessation of securities - IDX	28 Aug 2026 5:04PM	$2.250	$2.350	risen by 4.44%
Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID	Health Care	$877	Notification regarding unquoted securities - IDX	28 Aug 2026 4:54PM	$2.250	$2.350	risen by 4.44%
Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID	Health Care	$877	Notification of cessation of securities - IDX	28 Aug 2026 4:42PM	$2.250	$2.350	risen by 4.44%
Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID	Health Care	$877	Notification regarding unquoted securities - IDX	28 Aug 2026 11:28AM	$2.260	$2.350	risen by 3.98%
Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID	Health Care	$877	Change of Director's Interest Notice - Ingrid Player NED	28 Aug 2026 8:06AM	$2.330	$2.350	risen by 0.86%
Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID	Health Care	$877	Change of Director's Interest Notice - Jason Martinez CEO	28 Aug 2026 8:05AM	$2.330	$2.350	risen by 0.86%

IDX Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2028F	C2	$15.50	18.80%	15.10	8.50	3.60%	0.0%
2027F	C2	$13.10	0.00%	17.90	7.50	3.20%	0.0%
2026A	$49.47	$13.10	70.40%	19.00	9.30	3.70%	100.0%

IDX Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F
Australian Clinical Labs Limited (ACL)	$519M	0.0442	-0.0111	0.0428	14.7012	14.8663	14.2564	4.68%	4.68%	4.50%
Healius Limited (HLS)	$309M	0.3915	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Integral Diagnostics Limited (IDX)	$854M	0.7037	0.0000	0.1877	17.5479	17.5479	14.7742	4.06%	3.28%	3.71%
Sonic Healthcare Limited (SHL)	$9,682M	0.0839	-0.0157	0.1040	16.9390	17.2099	15.5884	5.51%	5.36%	5.64%

IDX Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.39	17.90	1.29	2.00
Market	0.37	13.10	1.17	0.81
Sector	0.62	20.40	1.80	2.87

IDX Directors

Name	Position	Start Date
Mr Jason Martinez	Chief Executive Officer, Executive Director, Managing Director	6 Aug 2026
Mr Andrew James Fay	Non-Executive Director	18 Jul 2022
Ms Ingrid Anne Player	Non-Executive Director	29 Aug 2023
Ms Laura Nicole McBain	Non-Executive Director	20 Dec 2024
Dr Kevin (Kai-Chung) Shaw	Non-Executive Director	20 Dec 2024
Mr Manish Mittal	Non-Executive Director	5 Feb 2025
Mr James Tobias Hall	Non-Executive Director, Non-Executive Chairman	28 Sep 2023

Integral Diagnostics Limited (IDX) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
28 Aug 2026	PLAYER, Ingrid	Buy	Indirect Shares	10,000	$2.380	$23,800.000
28 Aug 2026	MARTINEZ, Jason	Buy	Direct Shares	30,000	$2.390	$71,700.000
24 Jun 2026	HALL, James	Buy	Direct Shares	51,300	$1.963	$100,701.900

See all changes in directors' interest & trades for Integral Diagnostics Limited (IDX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IDX Management

Name	Position
Craig White	Chief Financial Officer
John J Merity	Company Secretary

IDX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Integral Diagnostics Limited (IDX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
22,279,739 (5.98%)	Yarra Capital Management Limited

IDX Calendar of Events

Date	Event
24 August 2027	Report (Annual)
24 August 2027	Report (Prelim)
23 February 2027	Report (Interim)
29 October 2026	AGM
02 October 2026	Div Pay Date

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us